MIM to Announce Fourth Quarter and Fiscal 2004 Earnings on February 17

    Pharmaceutical Writers/Business Editors

    ELMSFORD, N.Y.--(BUSINESS WIRE)--Jan. 21, 2005--MIM Corporation (NASDAQ:MIMS) (CBOE:OQX) (PCX:OQX), a pharmaceutical healthcare organization, today announced that it will release fourth quarter and fiscal 2004 earnings on Thursday, February 17, before market open.
    MIM Corporation will host a conference call to discuss results on February 17, at 10:00 AM ET. Interested parties may participate in the conference call by dialing 800-288-8961 (US), or 612-332-0636 (International), 5-10 minutes prior to the start of the call. A replay of the conference call will be available from 1:30 PM ET on February 17 through 11:59 PM ET on February 24, by dialing 800-475-6701 (US), or 320-365-3844 (International), and entering access code 768144. A webcast of the conference call will also be available under the investor information section of the MIM Corporation website, www.mimcorporation.com.
    MIM Corporation (www.mimcorporation.com) is a pharmaceutical healthcare organization delivering innovative pharmacy benefit and healthcare solutions that provide results beyond expectations. We excel by harnessing our clinical expertise, sophisticated data management, and therapeutic fulfillment capability, and combine it with our dedicated, responsive team of professionals that understands our partners' needs. The result is cost-effective solutions enhancing the quality of patient life.

    This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.

--30--NR/ny*

CONTACT: MIM Corporation Barry A. Posner, 914-460-1638 bposner@mimcorporation.com or Investor Relations: The Anne McBride Co. Rachel Levine, 212-983-1702 x207 rlevine@annemcbride.com

KEYWORD: NEW YORK INDUSTRY KEYWORD: PHARMACEUTICAL MEDICAL EARNINGS CONFERENCE CALLS SOURCE: MIM Corporation

Copyright Business Wire 2005